Abstract Body

Antiretrovirals (ARVs) long-term efficacy and HIV-functional cure require the abolition of viral replication in every body compartment as well as the effect of the immune system. The olfactory mucosa (OM) is a unique tissue at the intersection of the central nervous (CNS) and lymphatic system; preliminary data suggest that HIV may persist in the OM despite antiretroviral treatment.

Patients with neurocognitive disorders were included in a diagnostic study and OM samples were obtained through nasal brushing. The analysis of ARVs concentrations in swabs was performed as follows on frozen swabs. They were weighted upon extraction and then inserted in PTFE tubes along with 40µl of internal standard (marked with stable isotopes) working solution plus 500 µl of water:methanol solution (30:70 v:v). These tubes were then vortex-mixed 10 sec and sonicated for 10 minutes at 40°C. The dry extracts were dissolved in 110 µL of water:acetonitrile:acetic acid (94.9:5:0.1 v:v:v) solution and 10 µl of acid phosphatase (0.5 X) and incubated for 1 hour at 37°C, in order to convert phosphate metabolites of NRTIs to the free form. The resulting extracts were analyzed by using HPLC/MS-MS, obtaining absolute amounts (ng): these results were then normalized for the estimated weight of the extracted material (the difference between the initial weight and after the extraction process). The lower limit of quantification was 0.3 ng per sample, corresponding to a mean concentration of 3 pg/mg of OM swab.

31 patients were included. They were mostly male (80.6%) and of European ancestry (96.8%); median age and BMI were 51 years (46-58) and 23.5 Kg/m2 (19.7-27.7). Median current and nadir CD4+ T-cells were 649/uL (360-965) and 185/uL (88-278); after a median o 33 months (8-123) months of virological suppression plasma, CSF and OM HIV RNA were below 20 copies/mL in 27 (87.1%), 22 (71%) and 29 (93.5%) participants. OM concentrations as well as OM to plasma and OM to CSF ratios are shown in Table 1: a marginal correlation between OM and plasma (rho=0.30, p=0.007) and CSF concentrations (rho=-0.22, p=0.072) was observed.

We developed a novel method for quantifying ARVs in mucosal tissues obtained through brushing swabs. In this small pilot study antiretroviral concentrations in the OM were highly variable with protease inhibitors showing the highest exposure. Further studies are needed to compare ARVs’ penetration and residual viral replication.